The new SARCLISA J-code J9227 is now available, effective October 1, 2020, to be used for reimbursement claims. Refer to the Billing and Coding Guide on the Resources page for additional details. MAT-US-2018558-v1.0-08/2020
Printed From:
MECHANISM OF ACTION
ADCC=antibody-dependent cell-mediated cytotoxicity; ADCP=antibody-dependent cellular phagocytosis; CDC=complement-dependent cytotoxicity; mAb=monoclonal antibody; NK=natural killer.